Perry SL - Search Results

1

Chemotherapy induces Notch1-dependent MRP1 up-regulation, inhibition of which sensitizes breast cancer cells to chemotherapy.

Kim B, Stephen SL, Hanby AM, Horgan K, Perry SL, Richardson J, Roundhill EA, Valleley EM, Verghese ET, Williams BJ, Thorne JL, Hughes TA. Kim B, et al. Among authors: perry sl. BMC Cancer. 2015 Sep 11;15:634. doi: 10.1186/s12885-015-1625-y. BMC Cancer. 2015. PMID: 26362310 Free PMC article.

2

Neoadjuvant chemotherapy induces expression levels of breast cancer resistance protein that predict disease-free survival in breast cancer.

Kim B, Fatayer H, Hanby AM, Horgan K, Perry SL, Valleley EM, Verghese ET, Williams BJ, Thorne JL, Hughes TA. Kim B, et al. Among authors: perry sl. PLoS One. 2013 May 2;8(5):e62766. doi: 10.1371/journal.pone.0062766. Print 2013. PLoS One. 2013. PMID: 23658771 Free PMC article.

3

Dichloroacetate induces apoptosis and cell-cycle arrest in colorectal cancer cells.

Madhok BM, Yeluri S, Perry SL, Hughes TA, Jayne DG. Madhok BM, et al. Among authors: perry sl. Br J Cancer. 2010 Jun 8;102(12):1746-52. doi: 10.1038/sj.bjc.6605701. Epub 2010 May 18. Br J Cancer. 2010. PMID: 20485289 Free PMC article.

4

Carcinoembryonic antigen is the preferred biomarker for in vivo colorectal cancer targeting.

Tiernan JP, Perry SL, Verghese ET, West NP, Yeluri S, Jayne DG, Hughes TA. Tiernan JP, et al. Among authors: perry sl. Br J Cancer. 2013 Feb 19;108(3):662-7. doi: 10.1038/bjc.2012.605. Epub 2013 Jan 15. Br J Cancer. 2013. PMID: 23322207 Free PMC article.

5

The utility of c-Met as a diagnostic tissue biomarker in primary colorectal cancer.

Armstrong GR, Khot MI, Tiernan JP, West NP, Perry SL, Maisey TI, Hughes TA, Jayne DG. Armstrong GR, et al. Among authors: perry sl. Int J Exp Pathol. 2021 Jun;102(3):172-178. doi: 10.1111/iep.12395. Epub 2021 May 5. Int J Exp Pathol. 2021. PMID: 33951261 Free PMC article.

6

Targeting glucose metabolism: an emerging concept for anticancer therapy.

Madhok BM, Yeluri S, Perry SL, Hughes TA, Jayne DG. Madhok BM, et al. Among authors: perry sl. Am J Clin Oncol. 2011 Dec;34(6):628-35. doi: 10.1097/COC.0b013e3181e84dec. Am J Clin Oncol. 2011. PMID: 20805739 Review.

7

A novel fluorescent c-met targeted imaging agent for intra-operative colonic tumour mapping: Translation from the laboratory into a clinical trial.

Armstrong GR, Khot MI, Portal C, West NP, Perry SL, Maisey TI, Tiernan JP, Hughes TA, Tolan DJ, Jayne DG. Armstrong GR, et al. Among authors: perry sl. Surg Oncol. 2022 Mar;40:101679. doi: 10.1016/j.suronc.2021.101679. Epub 2021 Nov 20. Surg Oncol. 2022. PMID: 34839199 Clinical Trial.

8

Retinoic acid-induced protein 3: identification and characterisation of a novel prognostic colon cancer biomarker.

Zougman A, Hutchins GG, Cairns DA, Verghese E, Perry SL, Jayne DG, Selby PJ, Banks RE. Zougman A, et al. Among authors: perry sl. Eur J Cancer. 2013 Jan;49(2):531-9. doi: 10.1016/j.ejca.2012.07.031. Epub 2012 Sep 26. Eur J Cancer. 2013. PMID: 23021913

9

An observational study on the expression levels of MDM2 and MDMX proteins, and associated effects on P53 in a series of human liposarcomas.

Touqan N, Diggle CP, Verghese ET, Perry S, Horgan K, Merchant W, Anwar R, Markham AF, Carr IM, Achuthan R. Touqan N, et al. BMC Clin Pathol. 2013 Dec 13;13(1):32. doi: 10.1186/1472-6890-13-32. BMC Clin Pathol. 2013. PMID: 24330579 Free PMC article.

10

Lymphangiogenesis in abdominal aortic aneurysm.

Scott DJ, Allen CJ, Honstvet CA, Hanby AM, Hammond C, Johnson AB, Perry SL, Jones PF. Scott DJ, et al. Among authors: perry sl. Br J Surg. 2013 Jun;100(7):895-903. doi: 10.1002/bjs.9128. Br J Surg. 2013. PMID: 23640666

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

133 results

Search Page